Canopy Growth (WEED) Competitors C$4.07 -0.31 (-7.08%) (As of 05:28 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider Trades WEED vs. CMED, EMC, OGI, ICC, LEAF, MGW, BE, BLO, SL, and MJNShould you be buying Canopy Growth stock or one of its competitors? The main competitors of Canopy Growth include CanniMed Therapeutics (CMED), Emblem (EMC), Organigram (OGI), ICC Labs (ICC), Leaf Mobile (LEAF), Maple Leaf Green World (MGW), Beleave (BE), Cannabix Technologies (BLO), Supreme Cannabis Company Inc, (SL), and Cronos Group (MJN). These companies are all part of the "cannabis" industry. Canopy Growth vs. CanniMed Therapeutics Emblem Organigram ICC Labs Leaf Mobile Maple Leaf Green World Beleave Cannabix Technologies Supreme Cannabis Company Inc, Cronos Group Canopy Growth (TSE:WEED) and CanniMed Therapeutics (TSE:CMED) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, risk, community ranking, analyst recommendations, valuation, institutional ownership, media sentiment, dividends and profitability. Do analysts recommend WEED or CMED? Canopy Growth presently has a consensus price target of C$6.26, suggesting a potential upside of 53.84%. Given Canopy Growth's stronger consensus rating and higher possible upside, equities analysts clearly believe Canopy Growth is more favorable than CanniMed Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Canopy Growth 3 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.25CanniMed Therapeutics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the media favor WEED or CMED? In the previous week, Canopy Growth had 3 more articles in the media than CanniMed Therapeutics. MarketBeat recorded 3 mentions for Canopy Growth and 0 mentions for CanniMed Therapeutics. Canopy Growth's average media sentiment score of 0.30 beat CanniMed Therapeutics' score of 0.00 indicating that Canopy Growth is being referred to more favorably in the media. Company Overall Sentiment Canopy Growth Neutral CanniMed Therapeutics Neutral Is WEED or CMED more profitable? CanniMed Therapeutics has a net margin of 0.00% compared to Canopy Growth's net margin of -259.94%. CanniMed Therapeutics' return on equity of 0.00% beat Canopy Growth's return on equity.Company Net Margins Return on Equity Return on Assets Canopy Growth-259.94% -87.26% -3.83% CanniMed Therapeutics N/A N/A N/A Do institutionals and insiders hold more shares of WEED or CMED? 9.4% of Canopy Growth shares are held by institutional investors. 0.2% of Canopy Growth shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Does the MarketBeat Community prefer WEED or CMED? Canopy Growth received 483 more outperform votes than CanniMed Therapeutics when rated by MarketBeat users. However, 75.85% of users gave CanniMed Therapeutics an outperform vote while only 62.08% of users gave Canopy Growth an outperform vote. CompanyUnderperformOutperformCanopy GrowthOutperform Votes64062.08% Underperform Votes39137.92% CanniMed TherapeuticsOutperform Votes15775.85% Underperform Votes5024.15% Which has better earnings and valuation, WEED or CMED? CanniMed Therapeutics has lower revenue, but higher earnings than Canopy Growth. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCanopy GrowthC$287.10M1.20-C$602.30M-C$7.91-0.51CanniMed TherapeuticsN/AN/AN/AN/AN/A SummaryCanopy Growth beats CanniMed Therapeutics on 8 of the 12 factors compared between the two stocks. Ad Brownstone ResearchDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but designed to power a $9 trillion AI revolution. And I’ve identified a little-known supplier Elon is depending on to make it all happen.I urge you to watch this video now. Get Canopy Growth News Delivered to You Automatically Sign up to receive the latest news and ratings for WEED and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart WEED vs. The Competition Export to ExcelMetricCanopy GrowthDrug Manufacturers IndustryMedical SectorTSE ExchangeMarket CapC$345.38MC$1.13BC$5.06BC$5.61BDividend Yield4.80%3.13%4.83%5.75%P/E Ratio-0.51113.20133.9127.87Price / Sales1.202,159.071,148.991,183.56Price / Cash1.639.9240.5678.85Price / Book0.623.134.763.30Net Income-C$602.30MC$149.12MC$118.62MC$286.42M7 Day Performance-12.10%-1.96%12.28%-3.92%1 Month Performance-23.35%-2.27%12.40%0.43%1 Year Performance516.67%104.70%31.63%36.04% Canopy Growth Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)WEEDCanopy Growth1.2143 of 5 starsC$4.07-7.1%C$6.26+53.8%+534.8%C$345.38MC$287.10M-0.512,700Analyst DowngradeNews CoverageCMEDCanniMed TherapeuticsN/AC$27.00-5.3%N/AN/AC$668.44MN/A0.00147,000EMCEmblemN/A$1.88+1.6%N/A+0.0%$245.45M$5.71M-9.89N/AOGIOrganigram3.2013 of 5 starsC$2.17+3.3%C$3.86+78.0%+26.7%C$235.60MC$149.21M-0.84987Analyst ForecastGap UpICCICC LabsN/AC$1.62-5.8%N/A+0.0%C$223.64MC$533,684.0095.29N/AGap UpLEAFLeaf MobileN/AC$2.59-1.9%N/AN/AC$198.42MC$83.74M58.86150MGWMaple Leaf Green WorldN/AC$0.79+777.8%N/A+0.0%C$111.69MN/A0.00N/APositive NewsGap UpBEBeleaveN/AN/AN/AN/A$0.00N/A0.00N/AHigh Trading VolumeBLOCannabix TechnologiesN/AN/AN/AN/AC$0.00N/A0.00N/AGap DownSLSupreme Cannabis Company Inc,N/AN/AN/AN/AC$0.00N/A0.00N/AGap DownHigh Trading VolumeMJNCronos GroupN/AC$12.15-1.9%N/A+0.0%C$1.73BN/A0.007,600 Related Companies and Tools Related Companies CanniMed Therapeutics Alternatives Emblem Alternatives Organigram Alternatives ICC Labs Alternatives Leaf Mobile Alternatives Maple Leaf Green World Alternatives Beleave Alternatives Cannabix Technologies Alternatives Supreme Cannabis Company Inc, Alternatives Cronos Group Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (TSE:WEED) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredMedia Humiliated: Demo of Elon’s Tech Proves They’re WrongElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is ...Brownstone Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAll of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredPlease don’t take this warning lightly…Something huge is about to hit the stock market. Wall St. legend Louis Navellier calls it: "The most signif...InvestorPlace | SponsoredWhy Buffett, Griffin and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Canopy Growth Corp Please log in to your account or sign up in order to add this asset to your watchlist. Share Canopy Growth With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
